Efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial

BACKGROUND: Neutropenia is a common complication from chemotherapy. Mecapegfilgramtim (code name HHPG-19K), a long-acting recombinant human granulocyte colony-stimulating factor (rhG-CSF), has been developed. This study was to evaluate the efficacy and safety of mecapegfilgrastim for reducing neutro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Transl Med
Main Authors: Xu, Fengrui, Zhang, Yang, Miao, Zhanhui, Zeng, Xiaohua, Wu, Biao, Cai, Li, Liu, Jinping, Wang, Shusen, Hu, Xichun, Zheng, Wenbo, Chen, Zhiyue, Yang, Qing, Jiang, Zefei
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2019
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6803220/
https://ncbi.nlm.nih.gov/pubmed/31700918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.07.95
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares